Recombinant IL23A (Guselkumab Biosimilar) antibody
This Mammalian Cells Monoclonal antibody specifically detects IL23A (Guselkumab Biosimilar) in ELISA. It exhibits reactivity toward Human.
Catalog No. ABIN7488023
$336.06
Plus shipping costs $50.00
Shipping to:
United States
Delivery in 7 to 8 Business Days
Quick Overview for Recombinant IL23A (Guselkumab Biosimilar) antibody (ABIN7488023)
Target
IL23A (Guselkumab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Mammalian Cells
Clonality
Monoclonal
Conjugate
This IL23A (Guselkumab Biosimilar) antibody is un-conjugated
Application
ELISA
Grade
Research Grade
-
-
Expression System
- Mammalian cells
-
Purpose
- Guselkumab Biosimilar - Anti-IL23A mAb
-
Characteristics
- Antibody Type: IgG1-lambda
-
Purification
- Recombinant antibody expressed in mammalien cells and purified.
-
Isotype
- IgG1 lambda
-
-
anti-IL23A (Guselkumab Biosimilar) (E239D), (M241L) antibody
Research Grade Reactivity: Human ELISA Host: Humanized Monoclonal unconjugated
-
-
Restrictions
- For Research Use only
-
-
-
Buffer
- PBS pH 7.5
-
Storage
- -80 °C
-
Storage Comment
- store at -80°C
-
-
- IL23A (Guselkumab Biosimilar)
-
Target Type
- Biosimilar
-
Background
-
CNTO-1959
Guselkumab is a human IgG1 lambda monoclonal antibody that targets interleukin-23. IL-23 is an inflammatory cytokine that is reponsible for the activation of the CD4+ T-helper (Th17) cell pathway in the inflammatory cascade that induces psoriatic plaque formation. Guselkumab has been used to treat psoriasis. -
CAS-No
- 1350289-85-8
Target
-
You are here:
